medigraphic.com
SPANISH

Salud Pública de México

Instituto Nacional de Salud Pública
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Authors instructions        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 5

salud publica mex 2014; 56 (5)

Cartas al editor

Full text How to cite this article

Language: Spanish
References: 27
Page: 423-430
PDF size: 253.76 Kb.


Key words:

No keywords

Text Extraction

No abstract.


REFERENCES

  1. Nelsen A, Trautner BW, Petersen NJ, Gupta S, Rodriguez-Barradas M, Giordano TP et al. Development and validation of a measure for intention to adhere to HIV treatment. AIDS Patient Care STDS 2012;26:329-334.

  2. Osterberg L, Blaschke T. Adherence to medication. New Engl J Med 2005;353:487-497.

  3. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997;50:105-116.

  4. Kunutsor S, Walley J, Katabira E, Muchuro S, Balidawa H, Namagala E et al. Clinic Attendance for medication refills and medication adherence amongst an antiretroviral treatment cohort in Uganda: a prospective study. AIDS Res Treat 2010;2010:872396.

  5. Colubi MM, Pérez-Elías MJ, Elías L, Pumares M, Muriel A, Zamora AM et al. Missing scheduled visits in the outpatient clinic as a marker of short-term admissions and death. HIV Clin Trials 2012;13:289-295.

  6. Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med 1999;131:81-87.

  7. Web of Science [consultado en octubre de 2012]. Disponible en: http://thomsonreuters. com/products-services/science/science-products 1/a-z/web-of-science/

  8. SINAVE/DGE. Sistema de Vigilancia Epidemiológica de Influenza [documento en internet] [consultado el 15 de noviembre de 2012]. Disponible en: http://sinave.gob.mx/

  9. Vargas-Parada L. H1N1: a Mexican perspective. Cell 2009;139(7):1203-1205.

  10. García-García ML. Respuesta de la autora (carta al editor). Salud Publica Mex 2014;56(1):3.

  11. Torres-Sánchez L. Estableciendo asociaciones (carta al editor). Salud Publica Mex 2014;56(1):2.

  12. Cruz-Hervert LP, Ferreira-Guerrero E, Díaz- Ortega JL, Trejo Valdivia B, Téllez-Rojo MM, Mongua-Rodríguez N, et al. Cobertura de vacunación en adultos y adultos mayores en México. Salud Publica Mex 2013;55 supl 2:S300-S306.

  13. Hernández-Ávila M. Epidemiología: diseño y análisis de estudios. México: Instituto Nacional de Salud Pública/Médica Panamericana, 2007.

  14. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3a ed. EUA: Lippincott Williams & Wilkins, 2008.

  15. Kleinbaum DG, Sullivan KM, Barker ND. A pocket guide to epidemiology. EUA: Springer, 2007.

  16. Szklo M, Nieto FJ. Epidemiology: beyond the basics. 2a ed. EUA: Jones and Bartlett, 2007.

  17. Savitz DA. Interpreting epidemiologic evidence: strategies for study design and analysis. EUA: Oxford, 2003.

  18. Observatorio de Mortalidad Materna. Numeralia 2009. Mortalidad materna en México [internet document]. Mexico: OMM, 2010. [Retrieved 2012 September 19]. Aviable at: http:// www.omm.org.mx/images/stories/documentos/ NumeraliaMM2009.pdf

  19. World Health Organization. WHO recommendations for prevention and treatment of preeclampsia and eclampsia. Geneva: WHO, 2011.

  20. Centro Nacional de Equidad de Género y Salud Reproductiva. Prevención, diagnóstico y manejo de la preeclampsia/eclampsia. Lineamiento técnico. México, DF: Secretaría de Salud, 2007.

  21. Van Dijk MG, Diaz-Olavarrieta C, Zuñiga PU, Gordillo RL, Gutiérrez MER, García SG. Use of magnesium sulfate for treatment of pre-eclampsia and eclampsia in Mexico. Int J Gynaecol Obstet 2013;121(2):110-114.

  22. Lumbiganon P, Gülmezoglu AM, Piaggio G, Grimshaw J. Magnesium sulfate is not used for pre-eclampsia and eclampsia in Mexico and Thailand as much as it should be. Bull World Health Organ 2007;85(10):763-767.

  23. Gómez J, Núñez RM. Data from SINERHIAS 2009, with data from SAEH 2008.

  24. Frenk J, González-Pier E, Gómez-Dantés O, Lezana MA, Knaul FM. Comprehensive reform to improve health system performance in Mexico. Lancet 2006;368(9546):1524-1534.

  25. Knaul FM, González-Pier E, Gómez-Dantés O, García-Junco D, Arreola-Ornelas H, Barraza- Lloréns M, et al. The quest for universal health coverage: achieving social protection for all in Mexico. Lancet 2012;380(9849):1259-1279.

  26. Laurell AC. Health system reform in Mexico: a critical review. Int J Health Serv 2007;37(3):515-535.

  27. Nigenda G. Social service in medicine in Mexico: an urgent and possible reform. Salud Publica Mex 2013;55:519-527.




2020     |     www.medigraphic.com

Mi perfil

CÓMO CITAR (Vancouver)

salud publica mex. 2014;56